- Austria
- Croatia
- France
- Italy
- Malta
- Spain
- Sweden
- United Kingdom
The EU – US mutual recognition of inspections entered into its operational phase earlier this month when eight countries became the first territories outside of the USA to have their inspectorates recognised by the FDA.
The agreement will see the EU and US recognise the inspections of manufacturing sites for human medicines that are conducted in their respective regions. The operational phase follows on from the June 2017 announcement by the European Commission that the FDA has the ‘capability, capacity and procedures’ in place to carry out Good Manufacturing Practice (GMP) inspections at a level that is equivalent to those carried out in the EU.
Eight countries have been chosen to join the scheme initially, having been assessed by the FDA. They are: